# LEAP Strategy for Neovascular Age-Related Macular Degeneration

> **NCT07744204** · NA · NOT_YET_RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 240 (estimated)

## Conditions studied

- Neovascular Age-related Macular Degeneration(nAMD)
- Wet Macular Degeneration

## Interventions

- **DEVICE:** Laser photocoagulation
- **DRUG:** Anti-VEGF agents

## Key facts

- **NCT ID:** NCT07744204
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2029-07-31
- **Final completion:** 2029-07-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-08-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07744204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07744204, "LEAP Strategy for Neovascular Age-Related Macular Degeneration". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07744204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*